<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00300001</url>
  </required_header>
  <id_info>
    <org_study_id>2005-0186</org_study_id>
    <nct_id>NCT00300001</nct_id>
  </id_info>
  <brief_title>Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes</brief_title>
  <official_title>Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Community Cancer Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Community Cancer Care</source>
  <brief_summary>
    <textblock>
      The primary research objective of this protocol is to evaluate the impact of integrating a
      home-based symptom monitoring system in the day-to-day care of cancer patients in community
      settings on the frequency of supportive symptom interventions, symptom severity, and quality
      of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomly assigned to one of two groups. One group will be offered an
      Internet assisted home-based symptom reporting system Cancer Symptom Monitor (CSM) for a
      twelve-month study period. Patient and care team evaluations will be measured using
      quantitative and qualitative methods (via focus groups). The second group will receive
      &quot;standard care&quot; without home-based symptom monitoring. Both groups will be evaluated at
      baseline, 1, 2, 3, 6, 9, &amp; 12 months, for symptom levels and overall quality of life during
      the twelve-month study period.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>300</enrollment>
  <condition>Cancer</condition>
  <condition>Solid Tumor</condition>
  <condition>Hematologic Malignancy</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        18 years old or older Diagnosis of solid tumor or hematologic malignancy Starting active
        treatment (chemotherapy or hormonal therapy) Must be able to give informed consent &amp;
        consent to use the Cancer Symptom Monitor -

        Exclusion Criteria:

        Inability to give informed consent Life expectancy of less than 3 months Subject has any
        kind of disorder that compromises the ability of the subject to give written informed
        consent and/or to comply with study procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dale E. Theobald, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Community Cancer Care, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dale E Theobald, PhD, MD</last_name>
    <phone>317-621-4325</phone>
    <email>dtheobald@ecommunity.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Donna L Butler, MSN</last_name>
    <phone>317-621-4305</phone>
    <email>dbutler@ecommunity.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Quality Oncology Care, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dale E Theobald, PhD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Regional Cancer Center-Community Hospital North</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dale E Theobald, PhD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morgan Hospital and Medical Center</name>
      <address>
        <city>Martinsville</city>
        <state>Indiana</state>
        <zip>46151</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dale E. Theobald, PhD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berger AM, Portenoy RK, Weissman DE., Eds. Principles and Practice of Supportive Oncology, 2nd Ed.; Lippincott-Raven: Philadelphia, 2002.</citation>
  </reference>
  <reference>
    <citation>Max MB, Portenoy RK, Laska EM, Eds. Oxford Textbook of Palliative Medicine, 2nd Ed.; Oxford Medical Publications: New York, 1998.</citation>
  </reference>
  <reference>
    <citation>Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston Park). 2002 Sep;16(9 Suppl 10):64-70. Review.</citation>
    <PMID>12380956</PMID>
  </reference>
  <reference>
    <citation>Chang VT, Ingham J. Symptom control. Cancer Invest. 2003;21(4):564-78. Review.</citation>
    <PMID>14533447</PMID>
  </reference>
  <reference>
    <citation>Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Ried LD, Turrisi AT 3rd, Unützer J, Vernon SW; National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003 Aug 6;95(15):1110-7. Review.</citation>
    <PMID>12902440</PMID>
  </reference>
  <reference>
    <citation>Oncology Nursing Society, Research Agenda, 2003-2205. Available at http://www.ons.org/images/PDFs/Research/2003Plan.pdf.</citation>
  </reference>
  <reference>
    <citation>Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998 Apr;16(4):1594-600.</citation>
    <PMID>9552071</PMID>
  </reference>
  <reference>
    <citation>McDonald MV, Passik SD, Dugan W, Rosenfeld B, Theobald DE, Edgerton S. Nurses' recognition of depression in their patients with cancer. Oncol Nurs Forum. 1999 Apr;26(3):593-9.</citation>
    <PMID>10214600</PMID>
  </reference>
  <reference>
    <citation>Theobald DE, Butler D, Abdullah M, Perkins A, Edgerton S, Dugan WM. Access to communication technologies in a sample of cancer patients in Indiana: An urban and rural survey. (Poster Discussion) National Rural Health Meetings, San Diego, 2004.</citation>
  </reference>
  <reference>
    <citation>Theobald DE, Butler D, Coburn J, et al. IVR-based cancer symptom assessment: Nurses’ expectations and perceived barriers. (Abstract) Am Soc Clin Oncol, New Orleans, 2004.</citation>
  </reference>
  <reference>
    <citation>Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004 May 1;100(9 Suppl):1995-2025. Review.</citation>
    <PMID>15108222</PMID>
  </reference>
  <reference>
    <citation>Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000 Oct 1;89(7):1634-46.</citation>
    <PMID>11013380</PMID>
  </reference>
  <reference>
    <citation>Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer. 1992 May 15;69(10):2469-77.</citation>
    <PMID>1568168</PMID>
  </reference>
  <reference>
    <citation>Kreuger RA. Focus Groups: A practical guide for Applied Research. Sage Publications: Thousand Oakes, CA, 1994.</citation>
  </reference>
  <reference>
    <citation>Munhall P. Nursing Research: A qualitative perspective, third edition. 2001.</citation>
  </reference>
  <reference>
    <citation>Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993 Mar;11(3):570-9.</citation>
    <PMID>8445433</PMID>
  </reference>
  <reference>
    <citation>Morgan, D. Focus Groups as Qualitative Research. Sage Publications. Thousand Oakes, CA, 1997.</citation>
  </reference>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2006</study_first_submitted>
  <study_first_submitted_qc>March 3, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2006</study_first_posted>
  <last_update_submitted>August 23, 2006</last_update_submitted>
  <last_update_submitted_qc>August 23, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2006</last_update_posted>
  <keyword>Cancer</keyword>
  <keyword>Symptom Management</keyword>
  <keyword>Supportive Symptom Interventions</keyword>
  <keyword>Symptom Severity</keyword>
  <keyword>quality of life</keyword>
  <keyword>Home-based symptom monitoring</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

